In this study we hypothesized that the use of metabolic syndrome criteria and insulin sensitivity criteria may serve as important screening tools for the presence of subclinical atherosclerosis and improve assessment of future cardiovascular disease risk in individuals with absence of traditional risk factors. Here, INS is linked to cardiovascular disorder.